Drug Trial Radar · NCT07773103
Endothelial Markers and Tadalafil Response
Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Aug 19, 2026
Primary completion
Aug 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Al-Azhar UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 19, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- Male only, from 30 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective cohort study will recruit eligible men attending the Urology/Andrology outpatient clinic. Baseline assessment will include demographic and clinical data, cardiovascular risk assessment, erectile-function questionnaires, routine laboratory investigations, brachial artery flow-mediated dilatation, carotid intima-media thickness, and selected circulating endothelial biomarkers including endothelin-1, nitrite/nitrate, high-sensitivity C-reactive protein, soluble vascular cell adhesion molecule-1, and soluble intercellular adhesion molecule-1. All participants will receive tadalafil 5 mg once daily for 12 weeks. Erectile function, adherence, and adverse events will be assessed during follow-up. The primary outcome will be clinical response at 12 weeks, defined as an improvement of at least 4 points in the IIEF-EF domain together with a positive response to the Global Assessment Question.
Conditions
- Vasculogenic Erectile Dysfunction
Interventions
Tadalafil 5mgDrug
All enrolled participants will receive tadalafil 5 mg orally once daily for 12 weeks as part of clinical management.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical response to tadalafil at 12 weeksTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
Cairo, Egypt · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.